Search research articles
Contact Us
Filters
Showing results (311-320 of 321) with videos related to
Page
of 33
Sort By:
Gastroenterology
|
August 28, 2001
Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats
X R Huang, C W Chun Hui, Y X Chen, et al.
Current Medicinal Chemistry
|
February 15, 2014
The Janus face of cathelicidin in tumorigenesis
W K K Wu, J J Y Sung, A S L Cheng, et al.
Gene Therapy
|
March 2, 2012
Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice
E K K Tai, W K K Wu, X J Wang, et al.
Oncogene
|
July 22, 2014
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer
K-H Lee, J-W Park, H-S Sung, et al.
International Journal of Cardiology
|
August 29, 1997
New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions
K K Koh, H H In, K H Lee, et al.
Helicobacter
|
January 22, 2008
Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils
Guo Qing Li, Harry H X Xia, Min Hu Chen, et al.
British Journal of Cancer
|
December 21, 2013
Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study
S Y Ryu, M H Kim, B H Nam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2025
Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008
S Y Ryu, W Deng, K Albuquerque, et al.
Gene Therapy
|
December 21, 2012
Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice
L Zhang, J Yu, C C M Wong, et al.
ESMO Open
|
March 11, 2026
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study
S Y Ryu, B H Nam, M H Kim, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 321) with videos related to
Sort By:
Page
of 33
Gastroenterology
|
August 28, 2001
Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats
X R Huang, C W Chun Hui, Y X Chen, et al.
Current Medicinal Chemistry
|
February 15, 2014
The Janus face of cathelicidin in tumorigenesis
W K K Wu, J J Y Sung, A S L Cheng, et al.
Gene Therapy
|
March 2, 2012
Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice
E K K Tai, W K K Wu, X J Wang, et al.
Oncogene
|
July 22, 2014
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer
K-H Lee, J-W Park, H-S Sung, et al.
International Journal of Cardiology
|
August 29, 1997
New scoring system using tumor markers in diagnosing patients with moderate pericardial effusions
K K Koh, H H In, K H Lee, et al.
Helicobacter
|
January 22, 2008
Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils
Guo Qing Li, Harry H X Xia, Min Hu Chen, et al.
British Journal of Cancer
|
December 21, 2013
Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study
S Y Ryu, M H Kim, B H Nam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2025
Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008
S Y Ryu, W Deng, K Albuquerque, et al.
Gene Therapy
|
December 21, 2012
Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice
L Zhang, J Yu, C C M Wong, et al.
ESMO Open
|
March 11, 2026
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study
S Y Ryu, B H Nam, M H Kim, et al.
Page
of 33